Ascletis Pharma Inc.
HKEX:1672.HK
Overview | Financials
Company Name | Ascletis Pharma Inc. |
Symbol | 1672.HK |
Currency | HKD |
Price | 1.58 |
Market Cap | 1,555,800,720 |
Dividend Yield | 0% |
52-week-range | 0.76 - 1.97 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jinzi Jason Wu Ph.D. |
Website | https://www.ascletis.com |
An error occurred while fetching data.
About Ascletis Pharma Inc.
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD